Accelerating the future of drug discovery

At Exscalate we master biological complexity combining our knowledge of pharmacology, artificial intelligence (AI) and supercomputing to design better drugs faster.

Learn More

Latest News and Updates

Working in partnership with pioneering biopharma start-ups and through collaborations with ambitious European projects, Exscalate’s AI-driven supercomputing platform is accelerating drug discovery with some very promising outcomes.

MetabolEx: Platform for Small-Molecule Metabolites Generation and Metabolic Pathway Prediction

25th June 2026

MetabolEx combines curated metabolic reaction rules with machine-learning prioritization to make metabolite prediction more focused, interpretable, and actionable in early drug discovery.

Large-Scale Inference of Molecular Polypharmacology: The New ProfhEX Platform for Bioactivity Estimation and Liability Assessment

13th February 2026

ProfhEX is a large-scale, ML-powered platform that predicts bioactivity across nearly 700 human targets, enabling early identification of off-target risks, polypharmacology profiles, and drug repurposing opportunities to support safer, more effective drug discovery